InvestorsHub Logo
Followers 99
Posts 3689
Boards Moderated 0
Alias Born 01/13/2018

Re: None

Sunday, 11/03/2019 8:41:39 PM

Sunday, November 03, 2019 8:41:39 PM

Post# of 4271
The thing I find the most comical about this whole situation is that shorts/hedges were able to fool people for so long on the whole Adamis management could somehow screw things up for Symjepi after the contracts were signed and Novartis a $51.9 billion, $1 billion a week business took control of all sales, marketing contracts etc.

That Adamis could muck up anything except in the depositing of the very large checks.

Even after seeing the Q's since then jump QoQ by 40-50% and now with the commercial launch 1 week into Q3 July 9th by Sandoz/Novartis before the nationwide commercial launch of Symjepi July 9th and before this in August.......

To ensure access for U.S. military personnel, retirees, and their dependents, SYMJEPI has been added to the Department of Defense’s (“DOD”) Uniform Formulary for Tricare, now effective as of early August. Public records indicate the DOD’s budget for epinephrine in fiscal 2016 was more than $57 million.

What do you think Thursday will bring? And when Zimhi sales/marketing/contracts are taken over by Sandoz/Novartis what then? Because although not announced yet, you can bet your last dollar that Novartis/Sandoz already has Zimhi locked up IMHO.

ADMP management screw things up with Symjepi, that is laughable. But was a good hustle by the manipulators and players.

Peace out
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADMP News